Breaking News

Quotient Sciences Acquires CDMO Pharmaterials

The move further expands Quotient’s footprint in the U.K.

Quotient Sciences, a drug development services organization, has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K.   The acquisition further supports the growth of Quotient’s Translational Pharmaceutics platform, following the acquisitions of SeaView Research and QS Pharma in February 2017   Pharmaterials has a significant track record in supporting the development of small molecule drug products for oral and inhaled deliv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters